a month ago
MNPR
AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Top 7%
#338 out of 5510 analysts
Average Return
+32.79%
Win Rate
65%43 out of 66
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Faeth Therapeutics IncFTH | +261.45% | $10.79 | $39.00 | 2026-06-11 - 2026-09-10 | Strong Buy |
Faeth Therapeutics IncFTH | +181.59% | $13.85 | $39.00 | 2026-06-15 - 2026-09-10 | Strong Buy |
Monopar TherapeuticsMNPR | +154.57% | $44.93 | $114.38 | 2025-09-09 - 2026-09-08 | Strong Buy |
Nurix Therapeutics IncNRIX | +148.17% | $10.40 | $25.81 | 2025-10-23 - 2026-09-10 | Strong Buy |
Nurix Therapeutics IncNRIX | +110.52% | $12.26 | $25.81 | 2025-11-04 - 2026-09-10 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
a month ago
IPHA
2 months ago
MNPR
4 months ago
ARVN
7 months ago
PVLA
9 months ago
NRIX
9 months ago
KYMR
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascentage Pharma Group InternationalAAPG | 5 | Strong Buy | $48.00 | +187.94% | Reiterates | 21 days ago |
Arrivent Biopharma IncAVBP | 2 | Strong Buy | $42.00 | +46.34% | Reiterates | a month ago |
Monopar TherapeuticsMNPR | 8 | Strong Buy | $133.00 | +20.95% | Maintains | a month ago |
Bicara Therapeutics IncBCAX | 2 | Strong Buy | $39.00 | +68.83% | Maintains | a month ago |
Innate Pharma SaIPHA | 2 | Strong Buy | $9.00 | +378.72% | Maintains | a month ago |
Arvinas IncARVN | 5 | Strong Buy | $18.00 | +106.66% | Reiterates | a month ago |
Faeth Therapeutics IncFTH | 3 | Strong Buy | $55.00 | +41.03% | Reiterates | 2 months ago |
Nurix Therapeutics IncNRIX | 8 | Strong Buy | $32.00 | +23.98% | Reiterates | 2 months ago |
Verastem IncVSTM | 7 | Strong Buy | $18.00 | +136.22% | Maintains | 2 months ago |
Kymera Therapeutics IncKYMR | 7 | Strong Buy | $134.00 | +14.53% | Reiterates | 3 months ago |
Immunitybio IncIBRX | 2 | Strong Buy | $12.00 | +55.44% | Reiterates | 4 months ago |
Aardvark Therapeutics IncAARD | 5 | Hold | N/A | N/A | Downgrades | 4 months ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $125.00 | +289.04% | Reiterates | 4 months ago |
Perspective Therapeutics IncCATX | 4 | Strong Buy | $14.00 | +405.42% | Reiterates | 6 months ago |
Palvella Therapeutics IncPVLA | 5 | Strong Buy | $215.00 | +42.96% | Maintains | 7 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $11.00 | +144.99% | Initiates Coverage On | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.